Skip to content

Study on the Association Mechanism Between Deqi of Abdominal Massage and Clinical Efficacy in Chronic Fatigue Syndrome: A Randomized Controlled Trial

Study on the Association Mechanism Between Deqi of Abdominal Massage and Efficacy Based on Multidimensional Spatiotemporal Characterization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001732
Enrollment
Unknown
Registered
2026-07-13
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic fatigue syndrome

Interventions

Deqi Group (Treatment Group):abdominal massage
Non-Deqi Group (Control Group):abdominal massage
Healthy Control Group:no intervention

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Meet the revised diagnostic criteria for chronic fatigue syndrome issued by the US Centers for Disease Control and Prevention in 1994; Aged 18 to 50 years old, with no restriction on gender; Have not received any interventions for chronic fatigue syndrome within 2 weeks prior to enrollment; Possess clear consciousness, cooperative behavior and coherent speech, and be capable of accurately describing subjective sensations; Voluntarily participate in this study and sign the written informed consent form.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they: have comorbid conditions known to cause chronic fatigue, including pregnancy, lactation, or planned pregnancy; have sustained a recent sports injury with incomplete recovery of daily activities; have concurrent malignant tumors, endocrine and metabolic disorders, or other chronic wasting diseases; have a history of alcohol or substance dependence; have severe cardiovascular or cerebrovascular disease, or hematological or infectious disease; have severe hepatic or renal dysfunction; have psychiatric disorders, cutaneous sensory impairment, or auditory dysfunction; or cannot tolerate massage therapy or present with skin infection at the treatment site.

Design outcomes

Primary

MeasureTime frame
Fatigue Scale-14;

Secondary

MeasureTime frame
Self-Rating Anxiety Scale;Hamilton Depression Scale;Adverse Event Rate;

Countries

China

Contacts

Public ContactZhang Wei

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

james399@126.com138 2059 0796

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026